Plant Comparison
Midland Hawthorn vs Great Mullein
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Midland Hawthorn and Great Mullein: they share 4 indicated uses (arthritis / joint pain, inflammation (general), insomnia / sleeplessness, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Midland Hawthorn | Great Mullein | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Insomnia / sleeplessness | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 5/10 | Stronger for Great Mullein |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The principal cardioactive and antioxidant constituents, the basis for extract standardisation.
Additional antioxidant constituents of the flower, leaf and fruit.
Anti-inflammatory iridoids contributing to the plant's traditional respiratory and anti-inflammatory use.
Mucilage gives the soothing demulcent action; saponins contribute to the traditional expectorant effect.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from anti-inflammatory action
inferred from expectorant action
inferred from anticancer action
inferred from anti-inflammatory action
inferred from sedative action
Safety, Cautions & Contraindications
Generally safe and well tolerated. High doses may cause low blood pressure and sedation. May interact with cardiac glycosides (digoxin) and antihypertensive drugs. Consult a physician before using with existing heart medications.
Duke (2002) rates hawthorn (Crataegus spp., including C. laevigata) as a triple-plus herb (+++) with Commission E approval (score 2-3) for decreasing cardiac output in functional Stage II heart insufficiency (NYHA). Clinical evidence supports hawthorn standardized extracts (80-500 mg, standardized to flavonoids or procyanidins) for angina, arrhythmia, atherosclerosis, and hypertension. Hawthorn may potentiate digitalis and other cardiac medications and is not considered suitable for self-medication without professional guidance (Duke, 2002).
Generally considered safe for short-term use. The tiny hairs on the leaves can cause irritation if tea is not properly filtered. No significant drug interactions documented. Not recommended during pregnancy or breastfeeding due to lack of safety data.
Duke (2002) rates mullein as ++ with clinical evidence (score 2) for its expectorant activity, consistent with Commission E approval for catarrh and inflammation of the respiratory tract. It functions as a demulcent and emollient for mucous membranes. Traditionally used for bronchitis, asthma, and earaches (oil infusion). Dose: 1.5–2 g dried flower or leaf as tea, three to four times daily. Duke notes an antiviral (antiherpetic) activity at the experimental level. The plant is generally well-tolerated with no known significant contraindications at therapeutic doses (Duke, 2002).
External Ids
Botanical Description
Small deciduous tree or large shrub with thorny branches and glossy, shallowly lobed leaves (less deeply cut than common hawthorn). Clusters of small, five-petalled white (occasionally pink) flowers with a strong scent appear in spring, followed by small red berries (haws), each usually containing two seeds (nutlets).[1]
Tall, stately biennial herb forming a low first-year rosette of large, soft, thick, densely woolly grey-green leaves; in the second year it sends up a single, tall, unbranched flowering spike densely packed with bright yellow, five-petalled flowers that open a few at a time.[1]
Habitat
Grows in woodland, woodland edges, hedgerows and scrub, typically on richer, damper soils than common hawthorn; native to western and central Europe.[1]
Grows on dry, sunny waste ground, roadsides, disturbed soil and rocky slopes; native to Europe, North Africa and Asia and widely naturalised in North America and elsewhere.[1]
Harvesting
Flowers are picked as they open in spring, leaves are picked with the young flowering shoots, and the ripe red berries (haws) are gathered in autumn; all three parts are used, often combined, in hawthorn preparations.[1]
The flowers are picked individually as they open through summer (since they open only a few at a time and quickly fade once picked); leaves are gathered from the first-year rosette or second-year plant and dried, with care to filter out the fine leaf hairs, which can irritate the throat if not strained from tea.[1]
Traditional Uses
Hawthorn flower, leaf and berry have a long European tradition, and substantial modern clinical study, as a cardiovascular tonic - supporting heart function, mild circulatory complaints and calming nervous tension - reflected in its traditional use for 'heart strengthening' and its modern standing as a well-studied botanical for mild heart failure symptoms.[1]
Great mullein has a long European and Native American tradition as a soothing demulcent and expectorant remedy for cough, bronchitis and irritated airways, and the flower has also been infused in oil as a traditional remedy for earache; the soft, woolly leaf gave rise to old names like 'flannel leaf' and 'velvet plant'.[1, 2]
Preparations
Leaf-and-flower extract standardised to flavonoid or oligomeric proanthocyanidin content, taken as tablets or capsules; the best-studied clinical form.
Dried flower or leaf infused in hot water and carefully strained (to remove fine irritant hairs) as a traditional demulcent cough and respiratory tea.
Dosage
The EU herbal monograph on Crataegus spp., folium cum flore gives dry extracts in divided daily doses of 240-900 mg (single dose 80-450 mg) or, for one quantified extract, 570-1750 mg daily (single dose 190-350 mg), in adults and elderly. If symptoms persist longer than 2 weeks a doctor should be consulted, and hawthorn is never used as a substitute for prescribed heart medication without medical supervision. Educational reference only, not a prescription.
The EU herbal monograph gives 1-2 g of the comminuted leaf and flower in 150 mL of boiling water as an infusion, up to 4 times daily (maximum 6 g daily), in adults and elderly. Educational reference only, not a prescription.
The EU herbal monograph gives 1.5-2 g of the flower in 150 mL of boiling water as an infusion, three to four times daily (daily dose 4.5-8 g), in adolescents, adults and elderly; the infusion should be carefully strained to remove the irritant hairs. The monograph covers the FLOWER (Verbasci flos) only — it gives no posology for the leaf. Not recommended under 12 years. Educational reference only, not a prescription.
References
Drug Class Interactions
Not documented
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Fong, H.H.S. and Bauman, J.L (2002) 'Hawthorn', Journal of Cardiovascular Nursing, 16(4), pp. 1-8. doi:10.1097/00005082-200207000-00002 Traditional / reference
https://doi.org/10.1097/00005082-200207000-00002 - Orhan, I.E (2018) 'Phytochemical and Pharmacological Activity Profile of Crataegus oxyacantha L. (Hawthorn) - A Cardiotonic Herb', Current Medicinal Chemistry, 25(37), pp. 4854-4865. doi:10.2174/0929867323666160919095519 Traditional / reference
https://doi.org/10.2174/0929867323666160919095519 - Ahmadipour, B., Kalantar, M., Abaszadeh, S. and Hassanpour, H (2024) 'Antioxidant and antihyperlipidemic effects of hawthorn extract (Crataegus oxyacantha) in broiler chickens', Veterinary Medicine and Science, 10(3), pp. e1414. doi:10.1002/vms3.1414 Preclinical
https://doi.org/10.1002/vms3.1414 - Rigelsky, J.M. and Sweet, B.V (2002) 'Hawthorn: pharmacology and therapeutic uses', American Journal of Health-System Pharmacy, 59(5), pp. 417-422. doi:10.1093/ajhp/59.5.417 Meta-analysis / review
https://doi.org/10.1093/ajhp/59.5.417 - Saeedi, G., Jeivad, F., Goharbari, M., Gheshlaghi, G.H. and Sabzevari, O (2018) 'Ethanol Extract of Crataegus Oxyacantha L. Ameliorate Dietary Non-Alcoholic Fatty Liver Disease in Rat', Drug Research, 68(10), pp. 553-559. doi:10.1055/a-0579-7532 Preclinical
https://doi.org/10.1055/a-0579-7532 - Mecheri, A., Benabderrahmane, W., Amrani, A., Boubekri, N., Benayache, F., Benayache, S. and Zama, D (2019) 'Hepatoprotective Effects of Algerian Crataegus oxyacantha Leaves', Recent Patents on Food, Nutrition & Agriculture, 10(1), pp. 70-75. doi:10.2174/2212798410666180730095456 Preclinical
https://doi.org/10.2174/2212798410666180730095456 - Benabderrahmane, W., Lores, M., Benaissa, O., Lamas, J.P., de Miguel, T., Amrani, A., Benayache, F. and Benayache, S (2019) 'Polyphenolic content and bioactivities of Crataegus oxyacantha L. (Rosaceae)', Natural Product Research, 35(4), pp. 627-632. doi:10.1080/14786419.2019.1582044 Preclinical
https://doi.org/10.1080/14786419.2019.1582044 - Ali, M., Muhammad, S., Shah, M.R., Khan, A., Rashid, U., Farooq, U., Ullah, F., Sadiq, A., Ayaz, M., Ali, M., Ahmad, M. and Latif, A (2017) 'Neurologically Potent Molecules from Crataegus oxyacantha; Isolation, Anticholinesterase Inhibition, and Molecular Docking', Frontiers in Pharmacology, 8, pp. 327. doi:10.3389/fphar.2017.00327 Preclinical
https://doi.org/10.3389/fphar.2017.00327 - Cuevas-Duran, R.E., Medrano-Rodriguez, J.C., Sanchez-Aguilar, M., Soria-Castro, E., Rubio-Ruiz, M.E., Del Valle-Mondragon, L., Sanchez-Mendoza, A., Torres-Narvaez, J.C., Pastelin-Hernandez, G. and Ibarra-Lara, L (2017) 'Extracts of Crataegus oxyacantha and Rosmarinus officinalis Attenuate Ischemic Myocardial Damage by Decreasing Oxidative Stress and Regulating the Production of Cardiac Vasoactive Agents', International Journal of Molecular Sciences, 18(11), pp. 2412. doi:10.3390/ijms18112412 Preclinical
https://doi.org/10.3390/ijms18112412 - Alp, H., Soner, B.C., Baysal, T. and Sahin, A.S (2014) 'Protective effects of Hawthorn (Crataegus oxyacantha) extract against digoxin-induced arrhythmias in rats', Anatolian Journal of Cardiology, 15(12), pp. 970-975. doi:10.5152/akd.2014.5869 Preclinical
https://doi.org/10.5152/akd.2014.5869 - Rothfuss, M.A., Pascht, U. and Kissling, G (2001) 'Effect of long-term application of Crataegus oxyacantha on ischemia and reperfusion induced arrhythmias in rats', Arzneimittel-Forschung, 51(1), pp. 24-28. doi:10.1055/s-0031-1299998 Preclinical
https://doi.org/10.1055/s-0031-1299998 - Khan, A., Akram, M., Thiruvengadam, M., Daniyal, M., Zakki, S.A., Munir, N., Zainab, R., Heydari, M., Mosavat, S.H., Rebezov, M. and Shariati, M.A (2022) 'Anti-anxiety Properties of Selected Medicinal Plants', Current Pharmaceutical Biotechnology, 23(8), pp. 1041-1060. doi:10.2174/1389201022666210122125131 Meta-analysis / review
https://doi.org/10.2174/1389201022666210122125131 - Rastogi, S., Pandey, M.M. and Rawat, A.K.S (2015) 'Traditional herbs: a remedy for cardiovascular disorders', Phytomedicine, 23(11), pp. 1082-1089. doi:10.1016/j.phymed.2015.10.012 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2015.10.012 - European Medicines Agency (2016) 'European Union herbal monograph on Crataegus spp., folium cum flore'. Traditional / reference
https://scholar.google.com/scholar?q=European%20Union%20herbal%20monograph%20on%20Crataegus%20spp.%2C%20folium%20cum%20flore - Hendel, N. and Hendel, M (2014) 'Hedgerow Medicine'. Traditional / reference
https://scholar.google.com/scholar?q=Hedgerow%20Medicine - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure'. Traditional / reference
https://scholar.google.com/scholar?q=Hawthorn%20extract%20for%20treating%20chronic%20heart%20failure - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Tankanow, R., Tamer, H.R., Streetman, D.S., Smith, S.G., Welton, J.L., Annesley, T., Aaronson, K.D. and Bleske, B.E (2003) 'Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha)', Journal of Clinical Pharmacology, 43(6), pp. 637-642. doi:10.1177/0091270003253417 Randomized trial
https://doi.org/10.1177/0091270003253417 - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD005312.pub2 - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD005312.pub2 - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
- Turker, A.U. and Gurel, E (2005) 'Common mullein (Verbascum thapsus L.): recent advances in research', Phytotherapy Research, 19(9), pp. 733-739. doi:10.1002/ptr.1653 Meta-analysis / review
https://doi.org/10.1002/ptr.1653 - Gupta, A., Atkinson, A.N., Pandey, A.K. and Bishayee, A (2022) 'Health-promoting and disease-mitigating potential of Verbascum thapsus L. (common mullein): A review', Phytotherapy Research, 36(4), pp. 1507-1522. doi:10.1002/ptr.7393 Meta-analysis / review
https://doi.org/10.1002/ptr.7393 - Ali, N., Ali Shah, S.W., Shah, I., Ahmed, G. and others (2012) 'Anthelmintic and relaxant activities of Verbascum thapsus (Mullein)', BMC Complementary and Alternative Medicine, 12, pp. 29. doi:10.1186/1472-6882-12-29 Preclinical
https://doi.org/10.1186/1472-6882-12-29 - Mahdavi, S., Amiradalat, M., Babashpour, M., Sheikhlooei, H. and others (2020) 'The Antioxidant, Anticarcinogenic and Antimicrobial Properties of Verbascum thapsus L', Medicinal Chemistry, 16(7), pp. 991-995. doi:10.2174/1573406415666190828155951 Preclinical
https://doi.org/10.2174/1573406415666190828155951 - Kashan, Z.F., Arbabi, M., Delavari, M., Hooshyar, H. and others (2015) 'Effect of Verbascum thapsus ethanol extract on induction of apoptosis in Trichomonas vaginalis in vitro', Infectious Disorders Drug Targets, 15(2), pp. 125-130. doi:10.2174/1871526515666150724114924 Preclinical
https://doi.org/10.2174/1871526515666150724114924 - Chen, S., Liu, H., Wang, S., Jiang, H. and others (2022) 'The Neuroprotection of Verbascoside in Alzheimer's Disease Mediated through Mitigation of Neuroinflammation via Blocking NF-kappaB-p65 Signaling', Nutrients, 14(7), pp. 1417. doi:10.3390/nu14071417 Preclinical
https://doi.org/10.3390/nu14071417 - Bampidis, V., Azimonti, G., Bastos, M.L. and others (EFSA FEEDAP Panel) (2021) 'Safety of a feed additive consisting of a tincture derived from Verbascum thapsus L. (great mullein tincture) for use in all animal species (MANGHEBATI SAS)', EFSA Journal, 19(7), pp. e06711. doi:10.2903/j.efsa.2021.6711 Meta-analysis / review
https://doi.org/10.2903/j.efsa.2021.6711 - Blanco-Salas, J., Hortigon-Vinagre, M.P., Morales-Jadan, D. and Ruiz-Tellez, T (2021) 'Searching for Scientific Explanations for the Uses of Spanish Folk Medicine: A Review on the Case of Mullein (Verbascum, Scrophulariaceae)', Biology, 10(7), pp. 618. doi:10.3390/biology10070618 Meta-analysis / review
https://doi.org/10.3390/biology10070618 - Taleb, S. and Saeedi, M (2021) 'The effect of Verbascum thapsus on episiotomy wound healing in nulliparous women: a randomized controlled trial', BMC Complementary Medicine and Therapies, 21(1), pp. 166. doi:10.1186/s12906-021-03339-6 Randomized trial
https://doi.org/10.1186/s12906-021-03339-6 - Soto, K.M., Luzardo-Ocampo, I., Lopez-Romero, J.M., Mendoza, S. and others (2022) 'Gold Nanoparticles Synthesized with Common Mullein (Verbascum thapsus) and Castor Bean (Ricinus communis) Ethanolic Extracts Displayed Antiproliferative Effects and Induced Caspase 3 Activity in Human HT29 and SW480 Cancer Cells', Pharmaceutics, 14(10), pp. 2069. doi:10.3390/pharmaceutics14102069 Preclinical
https://doi.org/10.3390/pharmaceutics14102069 - European Medicines Agency (HMPC) (n.d.) 'European Union herbal monograph on Verbascum thapsus L., V. densiflorum Bertol. and V. phlomoides L., flos (Verbasci flos)'. Available at: https://www.ema.europa.eu/en/medicines/herbal/verbasci-flos Traditional / reference
https://www.ema.europa.eu/en/medicines/herbal/verbasci-flos - Oliff, H.S. and Blumenthal, M (2003) 'Great mullein', pp. 30--31. Traditional / reference
https://scholar.google.com/scholar?q=Great%20mullein - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Turker, A.U. and Gurel, E (2005) 'Common mullein (Verbascum thapsus L.): recent advances in research', 19(9), pp. 733--739. doi:10.1002/ptr.1653 Traditional / reference
https://doi.org/10.1002/ptr.1653 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Lin, C.C. and Yang, C.C. and Phua, D.H. and Deng, J.F. and Lu, L.H (2010) 'An outbreak of foxglove leaf poisoning', Journal of the Chinese Medical Association, 73(2), pp. 97-100. doi:10.1016/S1726-4901(10)70009-5 Clinical study
https://doi.org/10.1016/S1726-4901(10)70009-5 - Janssen, R.M. and Berg, M. and Ovakim, D.H (2016) 'Two cases of cardiac glycoside poisoning from accidental foxglove ingestion', CMAJ, 188(10), pp. 747-750. doi:10.1503/cmaj.150676 Clinical study
https://doi.org/10.1503/cmaj.150676 - Woodland Trust (2024) 'Foxglove (Digitalis purpurea)'. Available at: https://www.woodlandtrust.org.uk/trees-woods-and-wildlife/plants/wild-flowers/foxglove/ Traditional / reference
https://www.woodlandtrust.org.uk/trees-woods-and-wildlife/plants/wild-flowers/foxglove/ - NC State Extension (2024) 'Verbascum thapsus (Common Mullein)'. Available at: https://plants.ces.ncsu.edu/plants/verbascum-thapsus/ Traditional / reference
https://plants.ces.ncsu.edu/plants/verbascum-thapsus/
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.